A retrospective real-world single-arm study evaluating the efficacy and safety of neoadjuvant chemotherapy in patients with selected limited-stage small-cell lung cancer
Zhang, Wengang, Li, Yujie, Nie, Jing, Zhao, Wencheng, Guo, Zhiyi, Li, Shunjia, Zhang, Qianqian, Bo, Bing, Chen, Xuyang, Ye Li, Chen, Zhimin, Wang, Hao, Xu, Kandi, Zhao, Lishu, Liu, Xinyue, Liu, Yujin, Li, Yuhang, Huang, Lihua, He, Yayi
- ISSN / E-ISSN
- — / —
- DOI
- 10.21037/tlcr-2025-209 ↗
- Volume · Issue · Pages
- 14 · 6 · —
- Publisher
- AME Publishing Company
- Article URL
- https://tlcr.amegroups.org/article/view/102013 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
30 Jun 2025
Publisher publication date · source: Journal websites (OAI-PMH feeds of Open Journal Systems)
| Type | Date | Source |
|---|---|---|
| Publisher publication date | 30 Jun 2025 | Journal websites (OAI-PMH feeds of Open Journal Systems) |
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
Best available information, not a definitive status: Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
- Journal
- Translational Lung Cancer Research
- Publication date used
- 30 Jun 2025 (Publisher publication date)
- Applicable HEC period
- 2024–25 (version 1) · 01 Oct 2024 – 31 Mar 2026
- Category
- —
- Recognition status
- Pending Verification (PERIOD_HAS_UNMATCHED_ROWS)
- Source
- —
- Verification status
- Unverified
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.